Regional Health Propertie... (RHE)
AMEX: RHE
· Real-Time Price · USD
2.77
-0.00 (-0.15%)
At close: Feb 03, 2025, 2:05 PM
Regional Health Properties Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.19M | 5.66M | 4.22M | 4.33M | 4.13M | 4.52M | 4.14M | 4.6M | 3.91M | 10.15M | 11.03M | 8.09M | 6.65M | 6.44M | 6.7M | 6.47M | 7.08M |
Cost of Revenue | n/a | 3.13M | 2.33M | 2.85M | 2.76M | 3.01M | 2.62M | 2.45M | 2.83M | 6.72M | 9.07M | 6M | 4.16M | 4.08M | 4.25M | 4.04M | 4.01M |
Gross Profit | n/a | 2.53M | 1.9M | 1.48M | 1.37M | 1.51M | 1.52M | 2.14M | 1.08M | 3.43M | 1.96M | 2.09M | 2.49M | 2.36M | 2.46M | 2.42M | 3.07M |
Operating Income | -318K | 541K | -300K | 214K | -294K | 160K | -404K | 186K | -729K | 2.91M | 1.71M | -529K | -1.34M | 287K | 628K | 548K | 1.11M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 679K | 680K | 674K | 564K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.86M | -568K | -982K | -706K | -962K | -238K | -973K | -685K | -1.99M | -2.24M | -371K | -1.32M | -2.93M | -713K | -17K | -441K | 34K |
Net Income | -1.86M | -568K | -982K | -706K | -962K | -238K | -973K | -685K | -1.99M | -6.72M | -371.65K | -1.33M | -4.49M | -661K | -39K | -503K | 21K |
Selling & General & Admin | 2.23M | 1.32M | 1.22M | 1.23M | 1.63M | 786K | 972K | 1.01M | 1.21M | 1.22M | 1.38M | 921K | 1.12M | 951K | 972K | 945K | 1.04M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 668K | 973K | 550K | -1.66M | -1.35M | 139K | -192K | 602K | 1.15M | 1.04M | 1.7M | 2.7M | -353K | -122K | -323K | -394K |
Operating Expenses | 2.23M | 1.99M | 2.2M | 1.78M | 1.66M | 1.35M | 1.92M | 1.96M | 1.81M | 2.37M | 2.42M | 2.62M | 3.83M | 2.07M | 1.83M | 1.88M | 1.96M |
Interest Expense | 653K | 689K | 677K | 669K | 674K | 685K | 708K | 679K | 680K | 674K | 564K | 639K | 653K | 647K | 669K | 666K | 687K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 5.12M | 4.53M | 4.11M | 4.42M | 4.36M | 4.54M | 4.41M | 4.63M | 9.09M | 11.49M | 8.62M | 7.99M | 6.15M | 6.07M | 5.92M | 5.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.82K | 4.48M | 649.00 | 793.00 | 1.57M | n/a | n/a | 2.31K | 2.26K |
Shares Outstanding (Basic) | 1.99M | 1.93M | 1.9M | 1.85M | 1.84M | 1.84M | 1.88M | 1.88M | 1.86M | 1.77M | 1.77M | 1.77M | 1.79M | 1.75M | 1.77M | 1.7M | 1.69M |
Shares Outstanding (Diluted) | 1.99M | 1.93M | 1.9M | 1.85M | 1.84M | 1.84M | 1.88M | 1.88M | 1.86M | 1.77M | 1.77M | 1.77M | 1.79M | 1.77M | 1.77M | 1.7M | 1.69M |
EPS (Basic) | -0.94 | -0.29 | -0.52 | -0.38 | -0.52 | -0.13 | -0.52 | -0.36 | -1.07 | -3.8 | -0.21 | -0.75 | -2.51 | -0.38 | -0.02 | -0.3 | 0.01 |
EPS (Diluted) | -0.94 | -0.29 | -0.52 | -0.38 | -0.52 | -0.13 | -0.52 | -0.36 | -1.07 | -3.8 | -0.21 | -0.75 | -2.51 | -0.37 | -0.02 | -0.3 | 0.01 |
EBITDA | 84K | 684K | 169K | 728K | 223K | 677K | 122K | 888K | -235K | -985K | 2.31M | 77.00 | -726K | 925K | 1.28M | 1.2M | 1.76M |
EBIT | -318K | 121K | -305K | -37K | -294K | 447K | -265K | 186K | -1.31M | -113K | 193K | -686K | -2.27M | 287K | 630K | 163K | 708K |
Depreciation & Amortization | 402K | 563K | 474K | 514K | 511K | 517K | 526K | 702K | 510K | 585K | 600K | 606K | 613K | 638K | 651K | 652K | 650K |